Patents for A61P 27 - Drugs for disorders of the senses (53,017)
03/1999
03/16/1999US5883127 Vision defects, salts
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5883108 Combination therapy for treating glaucoma
03/16/1999US5882896 M protein
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999CA2244232A1 Novel def
03/16/1999CA2186513C Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
03/16/1999CA2073226C Pyrazolopyrimidinone antianginal agents
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
03/11/1999WO1999011605A1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
03/11/1999WO1999011275A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999WO1999011270A1 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
03/11/1999WO1999011258A1 Lymphocyte function antigen-1 antagonists
03/11/1999WO1999011244A1 Sustained release drug delivery devices
03/11/1999WO1999011239A1 Method for preparing pharmaceutical formulations
03/11/1999CA2302805A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999CA2301325A1 Method for preparing pharmaceutical formulations
03/11/1999CA2300850A1 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900843A2 FfH polypeptide from Streptococcus
03/10/1999EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/1999EP0900219A1 Heterocyclic compounds
03/10/1999EP0900218A1 Heterocyclic compounds
03/10/1999EP0900211A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
03/10/1999EP0900204A1 Heterocyclic compounds
03/10/1999EP0900202A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
03/10/1999EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
03/10/1999EP0900081A1 Inhibitors of farnesyl-protein transferase
03/10/1999EP0900080A1 Novel indole and benzothiazole derivatives
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880107 Sodium hyaluronate based ophthalmic formulation for use in eye surgery
03/09/1999US5880100 Method for inhibiting binding of human lens cells
03/09/1999CA2243656A1 Response regulator
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/04/1999WO1999010308A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
03/04/1999WO1999009985A1 Inhibitors of prenyl-protein transferase
03/04/1999WO1999009968A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption
03/04/1999WO1999009955A2 Lipid-containing compositions and uses thereof
03/04/1999WO1998055641A3 Somatic gene therapy to suppress secondary cataract formation
03/04/1999WO1998055606A3 Lactoferrin receptor genes of moraxella
03/04/1999CA2301770A1 Inhibitors of prenyl-protein transferase
03/04/1999CA2301519A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242258A1 Novel compounds
03/03/1999EP0899338A2 Seryl tRNA synthetase of Streptococcus pneumoniae (serS)
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899334A2 FtsZ polypeptides from Streptococcus pneumoniae
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899329A2 DextranaseB gene from Streptococcus pneumoniae
03/03/1999EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
03/03/1999CN1209743A Remedy for keratoconjunctival diseases
03/03/1999CA2242313A1 Signal recognition particle polypeptides and polynucleotides
03/02/1999US5877342 Skin disorders; respiratory system disorders; cardiovascular disorders
03/02/1999US5877211 Prostaglandins
03/02/1999US5877190 Substituted biphenyl compounds
03/02/1999US5877172 Process for isolating galanthamine
03/02/1999US5877154 Administering a polypeptide
03/02/1999US5876709 Ophthalmic composition containing active Vitamin D
03/02/1999CA2242315A1 Mecb
03/02/1999CA2242252A1 Dexb
03/02/1999CA2241417A1 Novel ffh
03/02/1999CA2062001C Stabilized pvp-i solutions
03/01/1999CA2242311A1 Novel compounds
02/1999
02/28/1999CA2241427A1 Novel pyrr homolog
02/28/1999CA2241400A1 Ftsy
02/26/1999CA2241431A1 Novel spoiiie
02/25/1999WO1999009147A1 Truncated platelet-activating factor acetylhydrolase
02/25/1999WO1999009146A1 Human serum inducible kinase (snk)
02/25/1999WO1999009049A1 Hypoxia-regulated genes
02/25/1999WO1999009046A1 Hypoxia-regulated genes
02/25/1999WO1999009025A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
02/25/1999WO1999008682A1 A method of preventing or treating estrogen-dependent diseases and disorders
02/25/1999WO1999008678A1 Heterocyclic vinylethers against neurological disorders
02/25/1999WO1999008636A1 Collagen-base auxiliary agent for ophthalmic surgery
02/25/1999WO1999008521A1 Treatment or prophylaxis of retinal pathology and spinal cord injury
02/25/1999CA2300135A1 Treatment or prophylaxis of retinal pathology and spinal cord injury
02/25/1999CA2269039A1 Collagen-base auxiliary agent for ophthalmic surgery
02/25/1999CA2241403A1 Murb
02/24/1999EP0897303A1 Inhibitors of farnesyl-protein transferase
02/24/1999EP0897301A1 Method of treating otitis media with uridine triphosphates and related compounds
02/24/1999CN1209123A New barbituric acid derivatives, processes for their prodn. and pharmaceutical agent contg. same
02/24/1999CN1209068A Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization
02/24/1999CN1209065A Otic microbial combinations
02/24/1999CN1208624A Application of theaflavine for prepn. of medicine for treating deafness
02/24/1999CN1042228C Antiallergic imidazoazepines
02/23/1999US5874460 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
02/23/1999US5874459 Reducing nausea during chemotherapy; therapy for glaucoma, organ transplants
02/23/1999US5874224 Growth factor receptor binding protein
02/18/1999WO1999007681A1 2-acylaminopropanamines as tachykinin receptor antagonists
02/18/1999CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists
02/17/1999EP0897011A2 Novel arginine deiminase